- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Swissray lands another multi-unit order
Digital x-ray manufacturer Swissray and marketing partner Hitachi Medical Systems America received a multi-unit order for Swissray’s ddR systems from American Radiology Services of Baltimore. ARS, which is affiliated with Johns Hopkins Imaging, owns
Digital x-ray manufacturer Swissray and marketing partner Hitachi Medical Systems America received a multi-unit order for Swissrays ddR systems from American Radiology Services of Baltimore. ARS, which is affiliated with Johns Hopkins Imaging, owns and operates 18 imaging centers and provides professional services for 14 hospitals in the Baltimore area.
In other news, Swissray has added yet another division to its growing stable of international offices. Swissray Romania SRL, located in Bucharest, Romania, will function as a wholly owned subsidiary of Swissray and will oversee implementation of the $13.8 million order received by Swissray from the Romanian Ministry of Health last September (SCAN 10/27/99). That order covers 32 ddRMulti-Systems, and delivery is expected to begin in March. Swissray Romania will also be responsible for future sales, marketing, and service activities for Swissray products in that country.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
